RxDoctor Payments Data

James White, MD

Otolaryngology · Lafayette, LANPI 1093001315

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Wound Management Technologies, Inc at 50.7% of the total. Reporting peaked in 2019 at $5,935 and has fallen 92.7% since, to $435 in 2025. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,617in general payments, 2019–2025

Across 151 payments — averaging $70.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Wound Management Technologies, Inc$5K
  • Aerin Medical Inc.$2K
  • Optinose US, Inc.$730
  • Medtronic$602
  • Regeneron Healthcare Solutions, Inc.$292
  • GSK$214
  • plus $904 from 16 others

What the payments were for

  • Consulting fees$5005%
  • Speaking & faculty fees$4,50042%
  • Travel & lodging$2,11220%
  • Food & beverage$3,50533%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,617 in reported general payments places this provider in the 90th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$243,972
Medicare patients
675
Services billed
4,792

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide75$2,092
Azelastine Hcl60$1,124
Pantoprazole Sodium73$846
Cefdinir45$784
Tobramycin-DexamethasoneTobramycin/Dexamethasone14$712
Famotidine73$534
Ondansetron OdtOndansetron73$516
Methylprednisolone71$367
Fluticasone Propionate52$362
Omeprazole27$358
Mupirocin44$330
Oxycodone Hcl52$247
Doxycycline Hyclate30$206
Levofloxacin14$194
Levothyroxine Sodium12$102

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →